|
|
BSc in Mathematics (University of La Rioja, 2022), MSc in Teaching in Secondary Education, Vocational Training and Language Instruction (University of La Rioja, 2023) and MSc in Physics and Mathematics (University of Castilla-La Mancha, 2025). Currently holding a FPI research fellowship. His research focuses on developing mathematical models for CAR T-cell therapy to better understand patient response and optimize treatment strategies.
|
Publications
Projects
- Mathematical modeling for the improvement of cellular immunotherapies and radiopharmaceutical treatments.
Partially supported by University of Castilla-La Mancha / ERDF, A way of making Europe (Applied Research Projects) under grant 2025-GRIN-38309 (2025 - 2028) - Model-based digital twins for biomarker development and virtual clinical trials in oncology.
Supported by project SBPLY/24/180225/000193, funded by Junta de Comunidades de Castilla-La Mancha. Spain and European Regional Development Fund (ERDF A way of making Europe). (2025 - 2028)
Sanz Galarreta, Pablo
|
BSc in Mathematics (University of La Rioja, 2022), MSc in Teaching in Secondary Education, Vocational Training and Language Instruction (University of La Rioja, 2023) and MSc in Physics and Mathematics (University of Castilla-La Mancha, 2025). Currently holding a FPI research fellowship. His research focuses on developing mathematical models for CAR T-cell therapy to better understand patient response and optimize treatment strategies.
|
Publications
Projects
- Mathematical modeling for the improvement of cellular immunotherapies and radiopharmaceutical treatments.
Partially supported by University of Castilla-La Mancha / ERDF, A way of making Europe (Applied Research Projects) under grant 2025-GRIN-38309 (2025 - 2028) - Model-based digital twins for biomarker development and virtual clinical trials in oncology.
Supported by project SBPLY/24/180225/000193, funded by Junta de Comunidades de Castilla-La Mancha. Spain and European Regional Development Fund (ERDF A way of making Europe). (2025 - 2028)
